| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CLDX | Common Stock | Options Exercise | $95,757 | +34,445 | +729% | $2.78* | 39,171 | 30 May 2024 | Direct | |
| transaction | CLDX | Common Stock | Options Exercise | $76,640 | +8,500 | +22% | $9.02 | 47,671 | 30 May 2024 | Direct | |
| transaction | CLDX | Common Stock | Sale | $1,298,384 | -38,597 | -81% | $33.64 | 9,074 | 30 May 2024 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CLDX | Incentive Stock Option (Right to Buy) | Options Exercise | $0 | -34,445 | -100% | $0.000000* | 0 | 30 May 2024 | Common Stock | 34,445 | $2.78 | Direct | F2 |
| transaction | CLDX | Incentive Stock Option (Right to Buy) | Options Exercise | $0 | -8,500 | -53% | $0.000000 | 7,500 | 30 May 2024 | Common Stock | 8,500 | $9.02 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.39 to $33.8934 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. |
| F2 | As of June 19, 2023, the option is fully vested. |
| F3 | As of June 13, 2022, the option is fully vested. |